This is a preview of subscription content, log in via an institution to check access.
References
Moser M. Rationale for combination therapy in the management of hypertension. J Clin Hypertens (Greenwich) 2003 Nov-Dec; 5(6 Suppl. 4): 17–25
Havranek EP, Esler A, Estacio RO, et al. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. Am Heart J 2003 Jun; 145(6): 993–8
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998 Jun 13; 351(9118): 1755–62
United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995 Jan 14; 310 (6972): 83–8
European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 Jun; 21 (6): 1011–53
Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec; 42(6): 1206–52
Turnbull F; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003 Nov 8; 362(9395): 1527–35
Moser M, Setaro J. Continued importance of diuretics and beta-adrenergic blockers in the management of hypertension. Med Clin North Am 2004 Jan; 88(1): 167–87
Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension: treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154(13): 1461–8
Neutel JM, Rolf CN, Valentine SN, et al. Low dose combination therapy as first line treatment of mild to moderate hypertension: the efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril and placebo. Cardiovasc Rev Rep 1996; 17: 33–45
Lewin AJ, Lueg MC, Targum S, et al. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension. Clin Cardiol 1993; 16(10): 732–6
Benetos A, Consoli S, Safavian A, et al. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension. Am Heart J 2000 Oct; 140(4): E11
Prisant LM, Weir MR, Papademetriou V, et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995 Aug; 130(2): 359–66
Narayan P, Papademetriou V. Effect of hydrochlorothiazide therapy on cardiac arrhythmias in African-American men with systemic hypertension and moderate to severe left ventricular hypertrophy. Am J Cardiol 1996 Oct 15; 78(8): 886–9
Prisant LM, Neutel JM, Papademetriou V, et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998 Sep; 5(5): 313–21
Rights and permissions
About this article
Cite this article
Industry Pulse. High Blood Press Cardiovasc Prev 13, 73–75 (2006). https://doi.org/10.2165/00151642-200613020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151642-200613020-00005